Prognostic Value of Tumor Deposit Counts in Patients with Stage III Colorectal Cancer: A Population-Based Study

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. doi:https://doi.org/10.1038/s41575-019-0189-8.
   PubMed Web of Science ®Google Scholar
• Weiser MR. AJCC 8th Edition: colorectal cancer. Ann Surg Oncol. 2018;25(6):1454–1455. doi:https://doi.org/10.1245/s10434-018-6462-1.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhao J, Li C, et al. The unique prognostic characteristics of tumor deposits in colorectal cancer patients. Ann Transl Med. 2019;7(23):769–769. doi:https://doi.org/10.21037/atm.2019.11.69.
   PubMedGoogle Scholar
• Pei JP, Zhang CD, Fu X, et al. A modified tumor-node-metastasis classification for stage III colorectal cancers based on treating tumor deposits as positive lymph nodes. Front Med (Lausanne). 2020;7:571154. doi:https://doi.org/10.3389/fmed.2020.571154.
   PubMed Web of Science ®Google Scholar
• Wang S, Guan X, Ma M, et al. Reconsidering the prognostic significance of tumour deposit count in the TNM staging system for colorectal cancer. Sci Rep. 2020;10(1):89. doi:https://doi.org/10.1038/s41598-019-57041-2.
   PubMed Web of Science ®Google Scholar
• Cohen R, Shi Q, Meyers J, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance). Ann Oncol. 2021;32(10):1267–1275. doi:https://doi.org/10.1016/j.annonc.2021.07.009.
   PubMedGoogle Scholar
• Nagtegaal ID, Knijn N, Hugen N, et al. Tumor deposits in colorectal cancer: improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol. 2017;35(10):1119–1127. doi:https://doi.org/10.1200/JCO.2016.68.9091.
   PubMedGoogle Scholar
• Lord AC, D’Souza N, Pucher PH, et al. Significance of extranodal tumour deposits in colorectal cancer: a systematic review and meta-analysis. Eur J Cancer. 2017;82:92–102. doi:https://doi.org/10.1016/j.ejca.2017.05.027.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:https://doi.org/10.1245/s10434-010-0985-4.
   PubMed Web of Science ®Google Scholar
• Sobin LH. TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol. 2003;21(1):19–22. doi:https://doi.org/10.1002/ssu.10017.
   PubMedGoogle Scholar
• Ueno H, Hashiguchi Y, Shimazaki H, et al. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. Am J Surg. 2014;207(1):70–77. doi:https://doi.org/10.1016/j.amjsurg.2013.04.009.
   PubMedGoogle Scholar
• Peparini N. Beyond T, N and M: the impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma. Surg Oncol. 2018;27(2):129–137. doi:https://doi.org/10.1016/j.suronc.2018.02.007.
   PubMed Web of Science ®Google Scholar
• Mirkin KA, Kulaylat AS, Hollenbeak CS, Messaris E. Prognostic significance of tumor deposits in stage III colon cancer. Ann Surg Oncol. 2018;25(11):3179–3184. doi:https://doi.org/10.1245/s10434-018-6661-9.
   PubMedGoogle Scholar
• Song YX, Gao P, Wang ZN, et al. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer? PLoS One. 2012;7(3):e34087. doi:https://doi.org/10.1371/journal.pone.0034087.
   PubMed Web of Science ®Google Scholar
• Jun L, Shengke Y, Junjie H, et al. Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study. Oncotarget. 2016;7(14):18269–18279.
   PubMedGoogle Scholar
• Jin M, Roth R, Rock JB, Washington MK, Lehman A, Frankel WL. The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome. Am J Surg Pathol. 2015;39(1):109–115. doi:https://doi.org/10.1097/PAS.0000000000000320.
   PubMedGoogle Scholar
• Kitamura K, Shida D, Sekine S, et al. Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer. Int J Clin Oncol. 2021;26(9):1671–1678. doi:https://doi.org/10.1007/s10147-021-01955-3.
   PubMedGoogle Scholar
• Liu C, Tian M, Pei H, Tan F, Li Y. Prognostic value of the N1c in stage III and IV colorectal cancer: a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database. J Invest Surg. 2022;35(4):850–859. doi:https://doi.org/10.1080/08941939.2021.1925787.
   Google Scholar
• Shi M, Zhang H, Yao G, et al. The role of tumor deposits in predicting the efficacy of chemotherapy in stage III colon cancer. Front Oncol. 2020;10:586603. doi:https://doi.org/10.3389/fonc.2020.586603.
   PubMedGoogle Scholar
• Delattre JF, Cohen R, Henriques J, et al. Prognostic value of tumor deposits for disease-free survival in patients with stage III colon cancer: a post hoc analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). JCO. 2020;38(15):1702–1710. doi:https://doi.org/10.1200/JCO.19.01960.
   PubMedGoogle Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(3):329–359. doi:https://doi.org/10.6004/jnccn.2021.0012.
   PubMed Web of Science ®Google Scholar
• Puppa G, Maisonneuve P, Sonzogni A, et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol. 2007;20(8):843–855. doi:https://doi.org/10.1038/modpathol.3800791.
   PubMed Web of Science ®Google Scholar
• Pricolo VE, Steingrimsson J, McDuffie TJ, McHale JM, McMillen B, Shparber M. Tumor deposits in stage III colon cancer: correlation with other histopathologic variables, prognostic value, and risk stratification-time to consider “N2c”. Am J Clin Oncol. 2020;43(2):133–138. doi:https://doi.org/10.1097/COC.0000000000000645.
   PubMedGoogle Scholar
• Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N + MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000;88(10):2228–2238. doi:https://doi.org/10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1.
   PubMedGoogle Scholar
• Basnet S, Lou QF, Liu N, et al. Tumor deposit is an independent prognostic indicator in patients who underwent radical resection for colorectal cancer. J Cancer. 2018;9(21):3979–3985. doi:https://doi.org/10.7150/jca.27475.
   PubMed Web of Science ®Google Scholar
• Frankel WL, Jin M. Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma. Mod Pathol. 2015;28 (Suppl 1):S95–S108. doi:https://doi.org/10.1038/modpathol.2014.128.
   PubMedGoogle Scholar
• Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:https://doi.org/10.1016/S1470-2045(14)71116-7.
   PubMed Web of Science ®Google Scholar